i-PRF Treatment for Severe Uterine Scarring and Fertility
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests a new treatment called i-PRF (a special growth-factor preparation made from your blood) injected into the uterus to help heal severe internal scarring (adhesions) that can prevent pregnancy. The goal is to restore the uterine lining so you can conceive naturally after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 20–40 years old
- You have moderate to severe uterine scarring (adhesions) from previous injury, confirmed by exam
- You have normal egg production and ovarian function
- You strongly want to become pregnant
- You are scheduled for surgery to remove scar tissue and rebuild your uterine cavity
- You can commit to follow-up visits and avoid certain blood-thinning medications before and after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if injecting a patient's own bone marrow stem cells into the uterus can help grow the lining in women with severe scarring and infertility. It might offer a new option for those who have not been able to have a frozen embryo transfer because their uterine lining stays too thin.
This trial tests a new product designed to prevent scar tissue (adhesions) from forming inside the uterus after surgery. If you have uterine scar tissue causing fertility problems or irregular periods, this study may help determine if the treatment is safe and effective.
This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.
This trial tests if a treatment called platelet-rich plasma (a concentration of your own blood cells) can help prevent scar tissue from coming back after surgery for Asherman's syndrome, a condition where scar tissue forms inside the uterus.
This trial tests whether injecting platelet-rich plasma (a concentrate from your own blood) into the uterus or ovaries can help women with certain fertility issues, such as damaged uterine lining, scarring, or low egg reserve. It aims to improve pregnancy chances in these challenging cases.
This study tests whether platelet-rich plasma (PRP)—a concentration of healing cells from your own blood—injected into the uterus can improve the uterine lining and help embryos implant successfully during fertility treatment. Researchers will check how the treatment changes immune cells in the uterus.
Hear when a new Intrauterine Adhesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.